AMBER ROGERS: Open Payments
NPI 1114561909 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 13 payments from 7 companies in 2025. Trend: 2023 $143 · 2024 $201 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $28 |
| PFIZER INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: CAPLYTA, REXULTI, Ozempic, Rybelsus, Veozah, PREVNAR 20, XIFAXAN, BEXSERO.
Industry payments across NE — which companies pay providers there.
